SPRC unit SciSparc advances PTSD-related MDMA-N-acylethanolamines IP
SPRC, via SciSparc and NeuroThera-Clearmind collaboration, advances intellectual property for MDMA-N-acylethanolamines aimed at treating PTSD.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.